HER2 overexpressing metastatic breast cancer.
| Publicado en: | Current Treatment Options in Oncology Vol. 3; no. 2; pp. 163 - 175 |
|---|---|
| Autores principales: | , , , |
| Formato: | review Journal Article |
| Publicado: |
Springer Nature
Apr2002
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=49509164&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 49509164 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15272729 3KHC jtl: Current Treatment Options in Oncology issn: 15272729 maglogo: N pubinfo: dt: Apr2002 vid: 3 iid: 2 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 49509164 49509164 NLM12057079 49509164 10.1007/s11864-002-0062-8 NLM12057079 49509164 ppf: 163 ppct: 12 formats: fmt: @attributes: type: P tig: atl: HER2 overexpressing metastatic breast cancer. aug: au: Spigel, David Burstein, Harold Spigel, David R Burstein, Harold J affil: Breast Oncology Center , Dana-Farber Cancer Institute , 44 Binney Street 02115 Boston USA sug: subj: Antineoplastic Agents, Combined Therapeutic Use Hydrocarbons Breast Neoplasms Breast Neoplasms Drug Therapy Genes Breast Neoplasms Pathology Neoplasm Metastasis Female Antibodies, Monoclonal Administration and Dosage Alkaloids Administration and Dosage Practice Guidelines Platinum Compounds Administration and Dosage Antibodies, Monoclonal Scales Female pubtype: Academic Journal doctype: review Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|